(Total Views: 162)
Posted On: 10/13/2021 10:15:26 AM
Post# of 38477
$AVCO News : Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases
https://marketwirenews.com/news-releases/aval...03303.html
(0)
(0)
